Foresters Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-27,000
Closed -$8.13M – 330
2018
Q4
$8.13M Buy
27,000
+2,900
+12% +$925K 0.15% 200
2018
Q3
$8.52M Buy
+24,100
New +$8.3M 0.13% 213
2018
Q1
– Sell
-5,062
Closed -$1.61M – 411
2017
Q4
$1.61M Buy
5,062
+2,862
+130% +$918K 0.03% 332
2017
Q3
$689K Buy
2,200
+231
+12% +$68.4K 0.01% 356
2017
Q2
$534K Buy
+1,969
New +$521K 0.01% 366

Other funds holding BIIB

Foresters Investment Management's BIIB Position: Q1 2019 in Review

Foresters Investment Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 27,000 shares — an estimated $8.13M sold.

Foresters Investment Management first reported a position in BIIB in Q2 2017 and held it in 5 quarters. The position peaked at $8.52M in Q3 2018. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Foresters Investment Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Foresters Investment Management sold 27,000 Biogen shares in Q1 2019, an estimated $8.13M.
  • Foresters Investment Management first reported a position in Biogen in Q2 2017 and held it in 5 quarters.
  • Foresters Investment Management's Biogen position peaked at $8.52M in Q3 2018.
  • 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Foresters Investment Management's 13F filing for Q1 2019, filed 15 May 2019.